Gut microbiota and diabetic kidney diseases: Pathogenesis and therapeutic perspectives
Jiaran Lin, Ziting Wang, Jiaojiao Sun, Yingying Yang, Xuexin Li, Xinru Wang, Yue Shi, Yuan‐Yuan Zhu, Ruiting Wang, Mina Wang, Feiyu Xie, Wei Peng, Zehuan Liao
Abstract
Diabetic kidney disease (DKD) is one of the major chronic complications of diabetes mellitus (DM), as well as a main cause of end-stage renal disease. Over the last few years, substantial research studies have revealed a contributory role of gut microbiota in the process of DM and DKD. Metabolites of gut microbiota like lipopolysaccharide, short-chain fatty acids, and trimethylamine N-oxide are key mediators of microbial-host crosstalk. However, the underlying mechanisms of how gut microbiota influences the onset and progression of DKD are relatively unknown. Besides, strategies to remodel the composition of gut microbiota or to reduce the metabolites of microbiota have been found recently, representing a new potential remedial target for DKD. In this mini-review, we will address the possible contribution of the gut microbiota in the pathogenesis of DKD and its role as a therapeutic target.